—Տ°y‘fŠw‚̐i•ΰ|ŒŒ΄y‘fˆΩνΗ‚Φ‚ΜƒAƒvƒ[ƒ`(2)

ƒCƒ“ƒgƒƒ_ƒNƒVƒ‡ƒ“
|ŒŒ΄y‘fƒf[ƒ^‚Μ•]‰Ώ|


›@–μ@„@Žj*
@@@@@@@@@@@@@@@@@@@@@@
IntroductionCAppreciation of Plasma Enzyme

Takashi KANNO, MD*

The heterogeneities of tissue enzymes and the enzyme distribution patterns of organs, tissues and plasma have now been established by many findings in various cases and diseases. Based on these precise laboratory data, the fields of clinical enzymology has been developed so as to analyze the very specific pathophysiological state in specific disorders. The characteristics of tumor-producing enzymes and genetically modified enzymes were additionally clarified by advances in molecular technology. Enzyme linked immunoglobulins were newly categorized enzyme abnormalities found in plasma enzymes. Genetical abnormalities of plasma enzymes fully explained the clotting abnormalities, hyper coagulability and hyperlipidemia. Based on these advances, the roles and future of clinical enzymology will be presented shown and discussed in this symposium.
[Rinsho Byori 50 : 563`565, 2002]

*Vice President of Hamamatsu University, School of Medicine, Hamamatsu 431-3192

yKey Wordszclinical enzymology(—Տ°y‘fŠw)Cgenetic abnormality(ˆβ“`“IˆΩν)Cenzyme linked immu-noglobulin(y‘fŒ‹‡«–Ζ‰uƒOƒƒuƒŠƒ“)Cplasma enzyme(ŒŒŸχy‘f)

*•lΌˆγ‰Θ‘εŠwE•›Šw’·(§431-3192 •lΌŽs”Ό“cŽR1-20-1)